Skip to content
Save up to 80% on your medications — Fast delivery
Albendazole
Guaranteed quality
Discreet shipping
Returns

Albendazole

4 customer reviews
Delivery: 4–7 days
Secure payment methods
24/7 Support
Active ingredient: Albendazole
Package Per unit Price
SSL Secure
Certified pharmacy
Money-back guarantee

Albendazole is a broad-spectrum anthelmintic medicine used against parasitic worm infections. It is for adults and children over 2 years with selected infections, and it works by disrupting parasite cell function so the worms lose energy and die.

What is it?

Albendazole is an antiparasitic medicine from the benzimidazole class, used as a broad-spectrum anthelmintic (a medicine that kills parasitic worms). In day-to-day prescribing, it’s chosen when you want “one medicine, wide coverage” for common intestinal worm infections, and it also has antiprotozoal activity for selected organisms.

A simple way to think about it: Albendazole targets the parasite’s internal “scaffolding,” so it can’t feed or multiply properly. This action is described in regulatory monographs used across Europe and internationally. [1]

Mechanism of Action

Albendazole blocks tubulin polymerization inside parasite cells, disrupting microtubules. Without functioning microtubules, parasites cannot absorb nutrients (including glucose), their energy stores fall, and they die. The broad-spectrum effect comes from hitting a core cellular process that many helminths share, across eggs, larvae, and adults.

Composition

Each tablet contains albendazole as the active substance. The formulation may also include standard tablet excipients such as fillers, binders, disintegrants, and lubricants to ensure stability, hardness, and proper release of the medicine. Albendazole is a benzimidazole anthelmintic used against a wide range of intestinal and tissue helminths.

How to use?

This product page is for Albendazole 400 mg tablets.

Tablets

Typical regimens used by clinicians include:

  • Ascariasis, enterobiasis (pinworm), ancylostomiasis (hookworm): 400 mg as a single dose for adults and children over 2 years; some cases need a repeat dose after a set interval to catch newly hatched worms.
  • Giardiasis in children (selected regimens): 400 mg once daily for 5 days.
  • Echinococcosis and some severe infestations: 400 mg twice daily in 28-day cycles with breaks, under specialist supervision and lab monitoring.
For multi-week courses (for example, echinococcosis protocols), clinicians often schedule liver function tests and blood counts at baseline and during therapy because changes can be silent at first.

How does it work?

Albendazole blocks tubulin polymerization inside parasite cells, disrupting microtubules. Without functioning microtubules, parasites cannot absorb nutrients (including glucose), their energy stores fall, and they die. The broad-spectrum effect comes from hitting a core cellular process that many helminths share, across eggs, larvae, and adults.

Indications

Albendazole is used for a range of parasitic infections caused by internal parasites. Clinically, it is often used for deworming, covering common nematodes such as pinworm/threadworm (Enterobius vermicularis), hookworm (including Ancylostoma duodenale), and roundworm (Ascaris lumbricoides). It is also used in some protocols for Strongyloides stercoralis, depending on local guidance and specialist preference.

Giardia is a protozoan (not a worm), yet albendazole can have antiprotozoal activity and is used in some settings, including paediatric regimens for giardiasis. More complex infections outside the gut include tissue infections such as neurocysticercosis and hydatid disease (echinococcosis), where treatment is planned and monitored by specialists because inflammation from dying parasites can drive symptoms. WHO guidance and training materials for helminth control also discuss albendazole’s role in population deworming programs. [2]

Common Intestinal Worms

  • Pinworm / threadworm (Enterobius vermicularis): often causes night-time perianal itching and household spread.
  • Hookworm (Ancylostoma duodenale): can contribute to iron-deficiency anaemia with heavy burden.
  • Roundworm (Ascaris lumbricoides): may cause abdominal symptoms and, rarely, obstruction with heavy infection.

Other Parasitic Infections

  • Giardia: protozoal intestinal infection; albendazole is one option in some paediatric treatment plans.
  • Strongyloides stercoralis: treatment choice varies; ivermectin is common, yet albendazole may be used in certain pathways.
  • Hydatid disease and neurocysticercosis: managed with imaging, staged courses, and adjunct medicines when indicated.

Comparison

Albendazole is a broad-spectrum anthelmintic medicine with activity across many intestinal worms and selected tissue parasites. It sits in the benzimidazole group (like mebendazole), which shares a microtubule-targeting mechanism. Other options work differently: pyrantel pamoate paralyses worms in the gut, and praziquantel targets tapeworm and fluke physiology.

A practical trade-off: albendazole is versatile, yet prolonged courses demand lab monitoring more than some single-dose, gut-only agents. Spectrum also matters; no single dewormer is “best” for every parasite.

Medicine Main coverage Practical considerations
Albendazole Broad intestinal worms; selected tissue infections; some antiprotozoal activity Simple for many cases; monitoring needed for long courses
Mebendazole Many intestinal nematodes Often used for gut-only infections; regimen varies by parasite
Pyrantel pamoate Pinworm, roundworm, hookworm (gut) Acts locally in the intestine; less useful for tissue parasites

Contraindications

Albendazole is not for you if any of the points below apply.

  • Allergic to albendazole or other benzimidazole medicines.
  • Pregnancy, especially the first trimester, because of teratogenic risk.
  • Breastfeeding, since active metabolites can pass into breast milk.
  • Severe liver dysfunction or active significant liver disease, unless a specialist judges benefit outweighs risk with close monitoring.
  • Children under 2 years unless a clinician specifically recommends it for a defined infection.

Drug interaction and safety points that matter in real practice:

  • Cimetidine, praziquantel, dexamethasone may increase levels of albendazole’s active metabolite, which can raise side-effect risk during longer courses.
  • Carbamazepine, phenytoin, phenobarbital can reduce active metabolite levels, which may reduce efficacy in tissue infections.
  • Warfarin and other anticoagulants: any significant infection and medication change can shift INR control; monitoring is commonly advised during multi-day treatment.

Not recommended for

Albendazole should be avoided if you are pregnant, especially in the first trimester, or if you are breastfeeding. It is also not a good fit if you have serious liver disease, a known allergy to albendazole or other benzimidazole medicines, or if a clinician has not recommended it for a child under 2 years.

Side effects

Most people tolerate short courses well, yet side effects can still happen. The most common issues are gastrointestinal upset (nausea, abdominal pain, diarrhoea, sometimes vomiting) plus headache or dizziness. Fatigue can show up, and some people notice disturbed sleep for a night or two after the dose.

More serious risks are uncommon but clinically important: raised liver enzymes, hepatitis, and bone marrow suppression (low white cells) have been reported more with prolonged or high-dose treatment. Skin reactions can occur, including urticaria in allergic individuals, and severe rashes are a medical emergency.

Common Side Effects

  • Nausea, abdominal pain, diarrhoea
  • Headache, dizziness, drowsiness or insomnia
  • Rash or itching
  • Temporary elevation of transaminases (liver enzymes)

Serious Warnings and Precautions

Liver inflammation can be symptom-free early on, so unexplained nausea, dark urine, marked fatigue, or yellowing of skin/eyes during a course should be treated as urgent. For neurocysticercosis, neurological symptoms can worsen during treatment due to inflammatory response around dying cysts, which is why steroid co-therapy and seizure management are handled by specialists. Safety warnings and monitoring recommendations are detailed in reference labels and regulator-reviewed documents.

A practical red flag I see missed: persistent fever or mouth ulcers during a longer course can signal low white blood cells. That’s a “stop and get checked today” scenario, not something to wait out.

Common mistakes

These are patterns pharmacists see repeatedly with Albendazole, and they explain a lot of “it didn’t work” stories.

  • Treating pinworm in one person only: Enterobius vermicularis spreads easily through household contacts, so isolated treatment often leads to rapid reinfection.
  • Skipping food with a longer course: for tissue infections, absorption matters; taking doses on an empty stomach can reduce exposure.
  • Using it during early pregnancy: patients sometimes treat “just in case” after travel; pregnancy status should be confirmed before dosing when relevant.
  • Assuming all itching is pinworm: haemorrhoids, dermatitis, and fungal infections can mimic it, and albendazole will not address those causes.
  • Ignoring lab follow-up on prolonged therapy: liver and blood count changes can be silent until they are clinically significant.
If symptoms persist after treatment, a stool test (ova and parasite exam) or targeted testing can prevent repeat dosing for the wrong cause.

Doctor opinions

Doctors like albendazole because it’s familiar, broad in coverage, and simple for many intestinal worms: one tablet can be the full course for selected infections. Infectious disease clinicians also value it in hydatid disease and neurocysticercosis plans, where it’s paired with imaging follow-up and supportive therapy rather than used as a stand-alone “quick fix.”

A point clinicians repeat: persistent symptoms after a single dose often mean reinfection, wrong diagnosis, or mixed infections rather than “resistance.” Another point: when a patient has unexplained abnormal liver tests, prescribers often choose a different approach or delay non-urgent deworming until the liver picture is clearer.

MOHAP-aligned practice in the UAE prioritises clear indications and safe use, especially in pregnancy and in prolonged regimens where lab monitoring changes decision-making. [3]

Frequently asked questions

For common intestinal worms, the medicine starts acting the same day, yet symptom relief can lag behind parasite death by a couple of days. Itching from Enterobius vermicularis may persist briefly due to irritation and eggs in the environment rather than ongoing adult worms. WHO materials on deworming programs describe why environmental control and repeat dosing schedules are sometimes used to reduce reinfection.

Albendazole is widely used for deworming, and many regimens include children older than 2 years when clinically indicated. Age, weight, and the parasite involved drive the final dosing plan, and some infections require repeat dosing. UAE practice aligns with careful avoidance in younger children unless specifically indicated.

Albendazole affects multiple parasite life stages by disrupting microtubules, which can reduce development and survival across larvae and adults. Egg eradication in real life is more complicated because eggs can persist in the environment (for example, pinworm eggs on bedding and surfaces). That’s why reinfection prevention is often part of the plan even when the pharmacology is strong.

For a single 400 mg dose, most side effects are mild and short-lived: nausea, abdominal pain, diarrhoea, and headache are common. Dizziness can occur, so some people choose to avoid driving until they know how they react. Longer courses raise the chance of liver enzyme elevations and blood count changes, so monitoring is used in those settings.

Pregnant patients, especially in the first trimester, should avoid albendazole because of fetal risk seen in animal data and reflected in regulator warnings. People with known hypersensitivity to albendazole or other benzimidazoles should not take it. Severe liver disease is also a key caution area, with specialist input used when treatment is essential.

Pinworm spreads easily through households, and eggs can survive on surfaces long enough to reinfect. Treating only one person, skipping hygiene measures, or missing a planned repeat dose can all lead to recurrence. Doctors often recommend coordinated treatment of close contacts plus cleaning and hand hygiene to break the cycle.

Front view Front view
Side view Side view
Back view Back view

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in. or 24x11x0.7 cm) and its contents cannot be seen.

Albendazole — Comparison with alternatives

Reviews and Experiences

H
Hassan, 34
Dubai
400 mg, single dose
Verified
I took it after a stool test showed roundworm. Mild stomach cramps that evening, then it settled. Within a week the abdominal bloating was gone.
12/10/2025
M
Mariam, 29
Abu Dhabi
400 mg, repeat dose plan
Verified
Used it for pinworm in the family. The first dose helped, but symptoms came back because we treated only one person at first. Second round with hygiene measures finally fixed it.
03/03/2025
R
Ravi, 41
Sharjah
400 mg daily for 5 days
Verified
It was prescribed for giardia. By day three my diarrhoea improved a lot, but I felt tired and had a dull headache most afternoons.
18/01/2025
N
Noor, 37
Al Ain
400 mg, single dose
Verified
No major side effects, just nausea for a few hours. I expected instant relief from itching, but it took a few nights and cleaning bedding mattered more than I thought.
27/08/2025

Sources

  1. European Medicines Agency (EMA) (2024). Summary of Product Characteristics (SmPC) — Albendazole (oral formulations).
  2. World Health Organization (WHO) (2025). Helminth control in school-age children: a guide for managers of control programmes (updated edition).
  3. MOHAP (Ministry of Health and Prevention) (2025). Public health guidance and patient information resources on intestinal parasites and deworming (UAE).
  4. U.S. Food and Drug Administration (FDA) (2024). Albendazole — Prescribing Information (label).
  5. National Library of Medicine — PubMed (2025). Review articles on albendazole therapy in neurocysticercosis and hydatid disease (bibliographic record collection).
Get our free app Shop faster and track your orders 3.8 · 1,437 reviews Install